I am happy to learn that the 5th Pakistan pharma Summit has been organized to being together all key industry stakeholders in order to deliberate on industry challenges, chalk out a plan of action for future growth and explore the opportunities for collaboration. Representation of international delegates in the summit is a an encouraging indicator for the local pharma sector which is seeking to develop more business linkages to boost exports.
We have envisioned our apex regulatory body for therapeutic goods to be the model authority in the world. In this context, many concrete steps and new initiatives have been taken to lift up not only our regulatory practice but industry as well. These steps include international harmonization, attainment of World Listed Authorities for DRAP, PIC/S membership, digitization and transparent working environment.
I would also take this opportunity to apprise all concerned stakeholders about the implementation of the Common Technical Documentation (CTD) system for registration of pharmaceutical companies, issuance of licenses, bringing in efficiency and transparency with a paperless mechanism.
Moreover, the construction of a purpose-built office for DRAP is also underway which will be completed by next year allowing us to operate in a fully computerized environment. We are also exploring opportunities for cooperation in the field of pharmaceutical manufacturing, availability of lifesaving drugs and vaccines, growth of the medical device industry, and provision of surgical items with neighboring countries. I extend my heartfelt gratitude and sincere thanks to the organizers of this summit and assure full support and cooperation.